Quantcast
Last updated on April 17, 2014 at 12:58 EDT

New Lawsuit filed on Denture Cream Poisoning: AttorneyOne.com provides Advice and Solutions for the ongoing Threat of Neuropathy from Denture Cream

February 24, 2012

According to court documents, on January 23rd, 2012, a Levittown, Pa. woman, Barbara Scholl filed a lawsuit (case no. 120102761) at Philadelphia´s Common Pleas Court against GlaxoSmithKline claiming that she suffered nerve weakness, decreased copper levels, axonal neuropathy and elevated zinc levels among others from using Super Poligrip. Super Poligrip (and its similar sister Poligrip) is a denture cream manufactured by GlaxoSmithKline. According to May 2011 report by Bloomberg News, sources said GlaxoSmithKline has settled more than 100 denture cream lawsuits, at an average cost of just over $1 million per case, to resolve claims brought by consumers who suffered permanent nerve damage due to zinc in the adhesive products. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Poligrip severe adverse events. http://www.attorneyone.com/denture-cream/

San Diego, CA (PRWEB) February 24, 2012

The media spotlight is often a double-edged sword. No one knows this better than Barbara Scholl. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

On January 23rd, 2012, a Levittown, Pa. woman, Barbara Scholl filed a lawsuit (case no. 120102761) at Philadelphia´s Common Pleas Court against GlaxoSmithKline claiming that she suffered nerve weakness, decreased copper levels, axonal neuropathy and elevated zinc levels among others from using Super Poligrip. The lawsuit was filed as a short-form complaint in the master denture adhesive cream litigation at Philadelphia´s Common Pleas Court.

According to the lawsuit information, the plaintiff claims that she started using the denture adhesive cream in 1996 and has continued through to present day. GlaxoSmithKline´s Poligrip and Super Poligrip contain zinc and increased levels of zinc may also cause reduced copper levels in the blood, known as hypocupremia, which may lead to neuropathy and affect the nerves. Researchers in Maryland published a study in April 1st, 2011 issue of General Dentistry confirming that excessive use of zinc-based denture adhesive cream may cause neurological damage and other problems from zinc poisoning.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Denture Cream severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe Denture Cream adverse events remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In February 2011, the FDA called for the removal of zinc from all denture adhesives while GlaxoSmithKline previously agreed to reformulate Super Poligrip to remove zinc in 2010. In February 2010, GlaxoSmithKline sent a “Dear Doctor” letter to dentists mentioning that the adverse event reports and the published literature suggest that excessive use of zinc-containing denture creams may lead to the development of excessive levels of zinc in the blood, associated with copper deficiency.

AttorneyOne.com has further information on Super Poligrip lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at http://www.prweb.com/releases/2012/2/prweb9220072.htm.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/2/prweb9223466.htm


Source: prweb